News
RSV vaccine race in balance as FDA sets May date for Pfizer ...
The FDA has started its review of Pfizer’s respiratory syncytial virus (RSV) vaccine for older adults, fast-tracking the biologics license application (BLA) with a decision due in May 2023.
